Table 2. Standard Chemotherapy Regimens for Wilms Tumor
| Regimen Name | Regimen Description |
| Regimen EE-4A [1] | Vincristine, dactinomycin x 18 weeks postnephrectomy |
| Regimen DD-4A [1] | Vincristine, dactinomycin, doxorubicin x 24 weeks postnephrectomy |
| Regimen I [2] | Vincristine, doxorubicin, cyclophosphamide, etoposide x 24 weeks |
References
- Grundy PE, Breslow NE, Li S, et al.: Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 23 (29): 7312-21, 2005. [PUBMED Abstract]
- Dome JS, Cotton CA, Perlman EJ, et al.: Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol 24 (15): 2352-8, 2006. [PUBMED Abstract]
